AdvaMed Touts Devices' Overall Economic Benefits, Echoing PhRMA Talking Point

The Advanced Medical Technology Association commended a Milken Institute study that shows the long-term benefits to patients and the economy from the investment in medical devices outweighs initial treatment expenditures. The stance echoes the pharmaceutical industry's new talking point that the high-cost of breakthrough drugs needs to be viewed in the context of the products' value to patients and the broader health care system. “[T]he economic benefits of reducing the burden of disease through better diagnosis, prevention, treatment, and cures...